| Peter, Nico (2019): Gezielte molekulare Therapie des diffusen großzelligen B-Zell-Lymphoms: In vitro Wirksamkeit der monoklonalen Anti-CD20-Antikörper Rituximab und Obinutuzumab sowie der PI3K-Inhibitoren LY294002 und Idelalisib in Mono- und Kombinationstherapie. Dissertation, LMU München: Faculty of Medicine |
Preview |
PDF
Peter_Nico.pdf 11MB |
DOI: 10.5282/edoc.25070
| Item Type: | Theses (Dissertation, LMU Munich) |
|---|---|
| Subjects: | 600 Technology, Medicine 600 Technology, Medicine > 610 Medical sciences and medicine |
| Faculties: | Faculty of Medicine |
| Language: | German |
| Date of oral examination: | 11. April 2019 |
| 1. Referee: | Dreyling, Martin |
| MD5 Checksum of the PDF-file: | 6adfafe85786a855f03ebcadb50bd160 |
| Signature of the printed copy: | 0700/UMD 18722 |
| ID Code: | 25070 |
| Deposited On: | 12. Nov 2019 15:51 |
| Last Modified: | 23. Oct 2020 14:51 |
Repository Staff Only: item control page
